Document is current

Article History

First Online: 18 December 2024

Conflict of interest

: S.M. Schmidt was a speaker for the following companies: Infectopharm, Mundipharma, Novartis, Olympus, Pari, Vertex, Sanofi, Milupa/received consulting fees from Vertex, Sanofi, Novartis/received/research support from Sanofi/Aventis, Pari, Boeringer Ingelheim. T. Ankermann was a speaker for the following companies: Abbvie, Aimmune, Allergopharma, ALK, Apothekerkammer Schleswig-Holstein, AstraZeneca GmbH, Chiesi, Danone, Engelhardt, Infectopharm, Nestle, Novartis, Nutricia, RG, Sanofi, Springer Verlag, UKSH Akademie, Conventus Congressmanagement & Marketing GmbH, B4c Solutions GmbH, R & G, GPP e.V, GPA e. V., nappa e. V., ÖGKJ e. V., Wissenschaftliche Verlagsgesellschaft, De Gruyter Verlag, Mcon Kongressmanagement/received consulting fees from Allergopharma. P. Fischer was a speaker for the following companies: Allergopharma und HAL. M. Gerstlauer was a speaker for the following companies: ALK-Abelló, Allergopharma, Bencard Allergie, Leti, Novartis, Sanofi, Stallergenes-Greer/received consulting fees from ALK-Abelló, Allergopharma, Bencard Allergie, Leti, Novartis, Sanofi, Stallergenes-Greer/research support from (in the last three years): Allergopharma, Bencard Allergie, Stallergenes-Greer, Boehringer Ingelheim, Infectopharm. M.V. Kopp was a speaker for the following companies: Sanofi Aventis GmbH, Infectopharm GmbH and Allergopharma GmbH/received consulting fees from Sanofi Aventis GmbH, Infectopharm GmbH and Allergopharma GmbH. B. Schaub was a speaker for the following companies: Sanofi/received consulting fees from GlaxoSmithKline, Novartis, Sanofi/research support from the German center for lung research (BMBF), the German Center for Child and Adolescent Health and the German Scientific community (DFG). C.P. Bauer, M. Gappa, S. Lau, C. Lex, B. Mischo, T. Spindler and C. Vogelberg declared no conflict of interest.